je.st
news
Merck's Vytorin first cholesterol drug to cut risk further
2014-11-18 09:37:30| Biotech - Topix.net
Merck & Co.' s Vytorin reduced the risks of second heart attacks and strokes in patients already on aggressive therapy, making it the first medicine to improve on the current standard of care for lowering cholesterol.
Tags: further
risk
cut
drug
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||